VORICONAZOLE- voriconazole injection, powder, lyophilized, for solution 
Cadila Healthcare Limited

----------

VORICONAZOLE FOR INJECTION

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - Container Label

NDC 70771-1413-1

Voriconazole

for Injection

200 mg per vial

Sterile Single-Dose Vial

For Intravenous Infusion Only

Rx Only

figure02

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - Carton Label

NDC 70771-1413-1

Voriconazole

for Injection

200 mg per vial

Sterile Single-Dose Vial

For Intravenous Infusion Only

1 Vial

Rx Only

figure03
VORICONAZOLE 
voriconazole injection, powder, lyophilized, for solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70771-1413
Route of AdministrationINTRAVENOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
VORICONAZOLE (UNII: JFU09I87TR) (VORICONAZOLE - UNII:JFU09I87TR) VORICONAZOLE10 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
SULFOBUTYLETHER .BETA.-CYCLODEXTRIN (UNII: 2PP9364507)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70771-1413-11 in 1 CARTON01/03/2019
120 mL in 1 VIAL, SINGLE-DOSE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20898301/03/2019
Labeler - Cadila Healthcare Limited (918596198)
Establishment
NameAddressID/FEIBusiness Operations
Cadila Healthcare Limited918596198ANALYSIS(70771-1413) , MANUFACTURE(70771-1413)

Revised: 10/2020
Document Id: c8911fb5-e7ec-4e7c-974b-1d691e377a27
Set id: 41c0c17b-0861-420d-bbfc-6e1143a05b40
Version: 3
Effective Time: 20201012
 
Cadila Healthcare Limited